Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR-T Cells for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1
San Francisco, California
This trial will test if it's safe to give patients their own genetically modified T cells, which have been changed to target the B cell surface antigen CD19.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.